Alpha Tau Medical Ltd Cl A DRTS

$13.23 -0.12 (-0.90%)

Valuation

Market cap
1,205,852,000
Revenue TTM
$0
Net income TTM
$-42,630,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.15

Trading

Volume
292,800
Avg volume
536,988
Day's range
$13.06 – $13.55
Shares out
90,326,000
Stochastic %K
57%
Beta
1.22
Analysts
Sell
Price target
$18.00

Price

Company profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors...

Show more

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 3 577 4115
Website
https://www.alphatau.com
Address
Kiryat HaMada St. 5, Jerusalem, Israel

Latest news

Stocktwits

Stock_Catcher Oct 30, 12:57 AM
Fortune Friday Watchlist Pt 5 $IOVA $SLS $DRTS $IBRX $NAUT
0 replies
Merlintrader Oct 30, 12:24 AM
$DRTS Latest company news, Oct 29: Alpha Tau announced that its ordinary shares will join the TASE TA-90 and TA-125 indices effective Nov 5. Index membership is a market-structure event, separate from clinical or regulatory progress. Next clinical date: REGAIN data at SNO on Nov 13, 7:30-9:30 p.m. ET in Philadelphia, for recurrent brain tumors. The expanded protocol doesn't establish a marketing approval. The hub has been rebuilt and is free. The full 23-page research report is a PDF in our Research Library: https://www.merlintrader.com/alpha-tau-stock-hub/?v=snello Not investment advice.
0 replies
Herbgator Oct 29, 5:44 PM
$DRTS Fantastic https://x.com/alphatauinsight/status/2115861827271684214?a=53dh9CRPlqdeDSQIO1I&s=46
0 replies
Jessypenny Oct 29, 5:16 PM
$DRTS Lets go! https://alphatau.com/alpha-tau-announces-inclusion-in-the-flagship-ta-90-and-ta-125-indices-of-the-tel-aviv-stock-exchange/?_thumbnail_id=3431
0 replies
WallStWireAds Oct 29, 4:16 PM
$DRTS Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange >> https://caplynx.io/Glkt11W
0 replies
Herbgator Oct 29, 2:04 PM
$DRTS another job opening yesterday https://www.linkedin.com/jobs/view/4482519389/
0 replies
Jordan3333 Oct 29, 10:02 AM
$DRTS Today should be the official announcement that $DRTS will join the TA 90 in a week. This will bring great recognition and a large amount of buying.
2 replies
Jessypenny Oct 29, 9:06 AM
An official announcement concerning $DRTS’s inclusion in the TA-90 index is anticipated today. Israeli index-tracking funds will be required to build positions in $DRTS
0 replies